Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Director/PDMR Shareholding

10 Aug 2011 07:00

RNS Number : 0554M
Gresham Computing PLC
10 August 2011
 

Gresham Computing plc

 

Director's Dealings

 

Gresham Computing plc (the "Company") has received notification that on 9 August 2011, Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), acquired 100,000 ordinary shares in the Company at a price of 46.65 pence per share and acquired 50,000 ordinary shares in the Company at a price of 45.00 pence per share.

 

Kestrel Partners LLP, which Max Royde (Non-executive Director of the Company) is a partner of and holds a beneficial interest in, is the investment manager to Kestrel Opportunities. Mr Royde is also a shareholder in Kestrel Opportunities.

 

Kestrel Opportunities holds 3,627,854 ordinary shares in the Company, which represents approximately 6.2 per cent of the Company's issued share capital.

 

-ends-

 

For further information please contact:

Gresham Computing plcChris Errington, CEOKen Archer, ChairmanRob Grubb, CFO

+44 (0) 20 7653 0200

Singer Capital Markets LtdShaun Dobson, Partner and Joint Head of Corporate FinanceJames Maxwell, Director of Corporate Finance

+44 (0) 20 3205 7500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSUFIUFFSEIA
Date   Source Headline
30th May 20197:00 amRNSSignificant Clareti Contract
2nd May 20193:42 pmRNSResult of AGM
2nd May 20197:00 amRNSAGM Statement
26th Apr 20197:00 amRNSDirector's Dealing
4th Apr 20197:00 amRNSDirector's Dealing
4th Apr 20197:00 amRNSExercise of Options
29th Mar 20197:00 amRNSGrant of Options
28th Mar 20197:00 amRNSDirector's Dealing
27th Mar 20197:01 amRNSSignificant Clareti Contract with Tier 1 Bank
27th Mar 20197:00 amRNSNotice of AGM and Dividend Timetable
12th Mar 20197:00 amRNSFinal Results
7th Mar 201910:00 amRNSNotice of Results
7th Mar 20197:00 amRNSStrategic relationship with RegTek.Solutions
1st Feb 20197:00 amRNSSignificant Clareti Contract with Tier 1 Bank
29th Jan 201911:51 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSSale of VME mainframe software business
7th Jan 20193:45 pmRNSHolding(s) in Company
7th Jan 20193:45 pmRNSHolding(s) in Company
4th Jan 201912:00 pmRNSClareti Contract Signed & Trading Update
17th Dec 20187:00 amRNSExtension of Clareti innovation service
6th Dec 20187:00 amRNSTrading Update
10th Oct 20187:00 amRNSTrading Update
1st Oct 20183:01 pmRNSExercise of Options
26th Sep 20187:00 amRNSStrategic fintech partnership with major bank
4th Sep 20183:35 pmRNSHolding(s) in Company
27th Jul 20187:00 amRNSExercise of Options
24th Jul 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNotice of Results & Analyst Presentation
10th Jul 20187:00 amRNSHolding(s) in Company
4th Jul 201811:05 amRNSSecond Price Monitoring Extn
4th Jul 201811:00 amRNSPrice Monitoring Extension
4th Jul 20187:01 amRNSAcquisition of B2 Group
4th Jul 20187:00 amRNSTrading Update
18th May 20185:46 pmRNSHolding(s) in Company
17th May 20187:00 amRNSCapital Markets Day
10th May 20183:09 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Statement
9th May 20187:00 amRNSClareti Contract Win with Global Tier 1 Bank
26th Apr 20189:26 amRNSHolding(s) in Company
23rd Apr 20187:00 amRNSGresham win Queen's Award for Enterprise
19th Apr 20187:00 amRNSExercise of Options
17th Apr 20187:00 amRNSClareti Cloud Win
6th Apr 20187:00 amRNSExercise of Options
4th Apr 20187:00 amRNSNotice of Annual General Meeting
16th Mar 201810:34 amRNSHolding(s) in Company
15th Mar 201812:57 pmRNSGrant of Options
13th Mar 20187:00 amRNSFinal Results
27th Feb 20187:00 amRNSNotice of Results & Results Presentations
5th Feb 20187:00 amRNSDirectorate Change
15th Jan 20187:00 amRNSAppointment of Chief Marketing Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.